Method and apparatus for identifying microorganisms

Assignee: Warner Lambert Co LLC

•

Filing: 1977-10-17

•

Granted: 1981-09-08

•

Expires: 1997-10-17

📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The method and apparatus for testing the susceptibility of bacteria to antibiotics described in the U.S. Pat. No. 3,832,532 and related patents are adapted for identifying various strains of bacteria by determining the light scatter indices (LSI) for a special group of antimicrobials, which have particularly significant characteristics with respect to identifying the strains of microorganisms, and analyzing them by a computer method, such as a quadratic discriminant function statistical technique, to identify the microorganisms to which the antimicrobials are applied. It has been found that 14 antimicrobial agents provide an extremely reliable identification and it is believed that the identifying group of agents could be reduced without sacrificing too much reliability. The agents preferably should be those which are not in common therapeutic use to avoid errors resulting from strains which have become immune to various therapeutically-utilized antibiotic agents. A presently defined group of such agents includes approximately 36 members (later described herein of which a number can be selected for reliable identification purposes by statistical techniques).

Inventors

👤 Bruce H. Sielaff
👤 Julius Praglin
👤 James E. McKie, Jr.
👤 David K. Longhenry
👤 Alan C. Curtiss
👤 Charles B. Bidwell

Bibliographic Details

Application Number —

Jurisdiction US

Data Source google_patents

Last Synchronized 2026-11-01 09:58

CPC Classifications

C; C12; C12Q; C12Q1/00; C12Q1/02; C12Q1/04; C12M; C12M41/00; C12M41/30; C12M41/36

Claims Analysis

Total Claims: 5

Claim 1

Independent Claim 182 words

A method of identifying a strain of microorganism in a liquid sample comprising the steps of dividing the sample into at least 18 sub-samples, inoculating each of the sub-samples with a growth-inhibiting agent whose reaction with the sub-samples has characteristics capable of identifying the strain of microorganism in said sample, the identity and/or quantity of the growth-inhibiting agent inoculated into each of said sub-samples being different, incubating the sub-samples to develop potentially significant differences in the growth of microorganism in each of them, reading a measure of the growth of the microorganism in each sub-sample, and comparing the growth readings with a bank of microorganism-identifying data relative to said growth-inhibiting agents by quadratic discriminant function analysis, whereby the strain of microorganism in the sample is identified, said growth-inhibiting agents being selected from the group consisting of acriflavine, 9-amino-acridine, auramine O, brilliant green, cetrimide, cobalt chloride, cupric chloride, cycloserine, 3,5-dibromosalicylic acid, dodecylamine hydrochloride, 5-fluorouracil, floxuridine, malachite green, methylene blue, omadine disulfide, sodium omadine, sodium azide, thallous acetate, 2',3',4'-trihydroxyacetophenone, bacitracin, carbenicillin, cephalothin, colistin, kanamycin, methenamine mandelate, nalidixic acid, nitrofurantoin, novobiocin, polymyxin B and tetracycline.

Claim 2

Independent Claim 182 words

Claim 3

Dependent Claim 12 words

A method of claim 1, wherein said growth readings are obtained photometrically.

Claim 4

Dependent Claim 27 words

A method of claim 1 or 2, wherein one additional sub-sample is maintained free of a growth-inhibiting agent, said additional sub-sample being used as a control sub-sample.

Claim 5

Dependent Claim 134 words

A method of claim 3, wherein the concentrations of growth-inhibiting agents in the inoculated sub-samples are approximately as follows: acriflavine (5 or 20 mcg./ml), 9-aminoacridine (6.7 mcg./ml.), auramine 0 (107 mcg./ml.), brilliant green (1,2 or 3.3 mcg./ml.), cetrimide (80 mcg./ml.), cobalt chloride (250 mcg./ml.), cupric chloride (250 mcg./ml.), cycloserine (80 or 160 mcg./ml.), 3,5-dibromosalicylic acid (500 mcg./ml.), dodecylamine hydrochloride (12.5 or 50 mcg./ml.), 5-fluorouracil (5.3 mcg./ml.), floxuridine (6 or 24 mcg./ml.), malachite green (2 mcg./ml.), methylene blue (170 mcg./ml.), omadine disulfide (3.7 mcg./ml.), sodium omadine (5 mcg./ml.), sodium azide (50 mcg./ml.), thallous acetate (100 mcg./ml.), 2',3',4'-trihydroxy-acetophenone (250 mcg./ml.), bacitracin (12 units/ml.), carbenicillin (33 mcg./ml.), cephalothin (10 mcg./ml.), colistin (8.7 mcg./ml.), kanamycin (3.3 mcg./ml.), methenamine mandelate (667 mcg./ml.), nalidixic acid (4 mcg./ml.), nitrofurantoin (10 mcg./ml.), novobiocin (20 mcg./ml.), polymyxin B (33 mcg./ml.), tetracycline (0.33 mcg./ml.).

References Cited (Backward Citations)

US3804720A Cited

US3832532A Cited

US3895661A Cited

US3899011A Cited

US3901588A Cited

US3942899A Cited

US3934753A Cited

US4101383A Cited

US4024530A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage	Window Opens	Payment Deadline	Surcharge Period Until	Estimated Fee	Status
3.5 Years (Year 4)	1984-09-07	1985-03-09	1985-09-08	$2000.00	Window Closed / Lapsed
7.5 Years (Year 8)	1988-09-07	1989-03-09	1989-09-08	$3760.00	Window Closed / Lapsed
11.5 Years (Year 12)	1992-09-07	1993-03-09	1993-09-08	$7700.00	Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag

Select Category

Notes (Optional)